N/A
N=53
Chlorhexidine Dressings for Hemodialysis Catheter Exit Site Care: Comparative Study
Hemodialysis Catheter Infection
Bottom Line
View on ClinicalTrials.gov: NCT05855616 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcome: Primary: Bacteraemia Rate — 2; 1 episodes — p=1.00
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Group "chlorhexidine dressing" (Device); Group "solution" (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hospital Universitario Marqués de Valdecilla
- Primary completion
- Jul 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bacteraemia Rate |
2; 1 | 1.00 |
| PRIMARY Exit Site Infection Rate |
2; 12 | 0.013 sig |
| PRIMARY Tunnelitis Rate |
0; 0 | — |
| SECONDARY Patient Satisfaction Rate |
0; 0; 0; 2; 3; 1 | 0.137 |
| SECONDARY Percentage of Hemodialysis Sessions With Skin Lesions |
99.1; 99; 0.9; 1 | 0.764 |
| SECONDARY Percentage of Hemodialysis Sessions With Dressing-related Skin Erythema Rate |
98.2; 99.2; 1.8; 0.8 | 0.055 |
Summary
The objective of this study is to compare the rate of hemodialysis catheter-related infections according to the treatment regimen: chlorhexidine gluconate dressing or chlorhexidine solution.
Eligibility Criteria
Inclusion Criteria
- Be included in the haemodialysis programme in our unit.
- Being a carrier of a tunneled central venous catheter as vascular access.
- Remain on haemodialysis treatment for at least 3 months in our unit.
- Consent to participate in the study.
Exclusion Criteria
- Allergy or hypersensitivity to chlorhexidine or intolerance to polyurethane dressing
- Active catheter-related infection.
Data sourced from ClinicalTrials.gov (NCT05855616). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.